(lp0
S'Uroplasty and Vision-Sciences to Merge, Creating Medical Device Company ... PR Newswire  - Dec 22, 2014 22, 2014 /PRNewswire/ -- Uroplasty, Inc.  and Vision-Sciences, Inc.  entered into a definitive merger agreement under which the two companies will combine in an all-stock transaction to create a new company expected to&nbsp;...Uroplasty To Merge With New York Device Maker, Change Name - Twin Cities Business Magazine'
p1
aS'Uroplasty and Vision-Sciences Complete Merger PR Newswire  - Mar 31, 2015 MINNEAPOLIS and ORANGEBURG, N.Y., March 31, 2015 /PRNewswire/ -- Uroplasty, Inc.  and Vision-Sciences, Inc.  today announced the completion of their merger.Minnetonka-based Uroplasty completes merger, changes name to Cogentix Medical - Minneapolis Star Tribune'
p2
aS'Uroplasty Inc. Announces CPT Category I Code and Associated Reimbursement ... PR Newswire  - Nov 2, 2010 2, 2010 /PRNewswire/ -- Uroplasty Inc. , announced today that the Centers for Medicare and Medicaid Services  has published, in the November, 2010 Federal Register, the anticipated Category I CPT code for Posterior Tibial Nerve&nbsp;...'
p3
aS'Uroplasty Announces Implanted Tibial Nerve Stimulator Long-Term Study ... PR Newswire  - Oct 15, 2012 MINNETONKA, Minn., Oct. 15, 2012 /PRNewswire/ -- Uroplasty, Inc. , a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that the results of a&nbsp;...'
p4
aS"Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement PR Newswire  - Mar 30, 2015 MINNEAPOLIS and ORANGEBURG, N.Y., March 30, 2015 /PRNewswire/ -- Uroplasty, Inc.  and Vision-Sciences, Inc.  shareholders have voted at the special meeting of each company's shareholders held today to approve the&nbsp;..."
p5
aS'Uroplasty Announces Positive Coverage Decision For Percutaneous Tibial Nerve ... PR Newswire  - Feb 24, 2015 24, 2015 /PRNewswire/ -- Uroplasty, Inc. , a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that Cigna has written a positive coverage policy ...'
p6
aS'Should You Sell Uroplasty, Inc. Based On Current Broker Views? NewsDen - 19 hours ago 09/29/2014 - Uroplasty, Inc. was upgraded to neutral by analysts at Zacks. They now have a USD 2.6 price target on the stock.'
p7
aS'Uroplasty CEO Resigns; Ex-MN Med-Tech Leader Steps In Twin Cities Business Magazine - Apr 8, 2013 Uroplasty is a medical device company that develops, manufactures, and markets medical products to treat bladder dysfunction and pelvic disorders.'
p8
aS'Uroplasty Provides Update On PTNS Reimbursement PR Newswire  - Dec 4, 2013 MINNEAPOLIS, Dec. 4, 2013 /PRNewswire/ -- Uroplasty, Inc.  a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today provided an update on&nbsp;...'
p9
aS"Uroplasty buying Vision-Sciences, forms Cogentix Medical Minneapolis / St. Paul Business Journal - Dec 22, 2014 Uroplasty Inc. said this morning that it would merge with fellow med-tech company Vision-Sciences Inc. to create a new company called Cogentix Medical Inc. The companies said that under the all-stock deal each share of Uroplasty's common stock will be&nbsp;..."
p10
a.